<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Klein F</submitter><funding>Swiss National Science Foundation</funding><funding>People Program</funding><pagination>638-655</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6400535</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>216(3)</volume><pubmed_abstract>T cell development is critically dependent on successful rearrangement of antigen-receptor chains. At the β-selection checkpoint, only cells with a functional rearrangement continue in development. However, how nonselected T cells proceed in their dead-end fate is not clear. We identified low CD27 expression to mark pre-T cells that have failed to rearrange their β-chain. Expression profiling and single-cell transcriptome clustering identified a developmental trajectory through β-selection and revealed specific expression of the transcription factor Duxbl at a stage of high recombination activity before β-selection. Conditional transgenic expression of Duxbl resulted in a developmental block at the DN3-to-DN4 transition due to reduced proliferation and enhanced apoptosis, whereas RNA silencing of Duxbl led to a decrease in apoptosis. Transcriptome analysis linked Duxbl to elevated expression of the apoptosis-inducing Oas/RNaseL pathway. RNaseL deficiency or sustained Bcl2 expression led to a partial rescue of cells in Duxbl transgenic mice. These findings identify Duxbl as a regulator of β-selection by inducing apoptosis in cells with a nonfunctional rearrangement.</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection.</pubmed_title><pmcid>PMC6400535</pmcid><funding_grant_id>315902</funding_grant_id><funding_grant_id>310030B_160330/1</funding_grant_id><funding_grant_id>160330</funding_grant_id><pubmed_authors>Klein F</pubmed_authors><pubmed_authors>von Muenchow L</pubmed_authors><pubmed_authors>Pelczar P</pubmed_authors><pubmed_authors>Rolink A</pubmed_authors><pubmed_authors>Engdahl C</pubmed_authors><pubmed_authors>Alberti-Servera L</pubmed_authors><pubmed_authors>Mitrovic M</pubmed_authors><pubmed_authors>Fehling HJ</pubmed_authors><pubmed_authors>Roux J</pubmed_authors><pubmed_authors>Tsapogas P</pubmed_authors></additional><is_claimable>false</is_claimable><name>The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection.</name><description>T cell development is critically dependent on successful rearrangement of antigen-receptor chains. At the β-selection checkpoint, only cells with a functional rearrangement continue in development. However, how nonselected T cells proceed in their dead-end fate is not clear. We identified low CD27 expression to mark pre-T cells that have failed to rearrange their β-chain. Expression profiling and single-cell transcriptome clustering identified a developmental trajectory through β-selection and revealed specific expression of the transcription factor Duxbl at a stage of high recombination activity before β-selection. Conditional transgenic expression of Duxbl resulted in a developmental block at the DN3-to-DN4 transition due to reduced proliferation and enhanced apoptosis, whereas RNA silencing of Duxbl led to a decrease in apoptosis. Transcriptome analysis linked Duxbl to elevated expression of the apoptosis-inducing Oas/RNaseL pathway. RNaseL deficiency or sustained Bcl2 expression led to a partial rescue of cells in Duxbl transgenic mice. These findings identify Duxbl as a regulator of β-selection by inducing apoptosis in cells with a nonfunctional rearrangement.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Mar</publication><modification>2026-05-05T06:31:16.063Z</modification><creation>2025-05-29T20:02:47.556Z</creation></dates><accession>S-EPMC6400535</accession><cross_references><pubmed>30765463</pubmed><doi>10.1084/jem.20181444</doi></cross_references></HashMap>